nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Sinus headache—Metformin—polycystic ovary syndrome	0.0279	0.0684	CcSEcCtD
Zalcitabine—Tooth abscess—Metformin—polycystic ovary syndrome	0.0218	0.0533	CcSEcCtD
Zalcitabine—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0191	0.0468	CcSEcCtD
Zalcitabine—Sinus congestion—Metformin—polycystic ovary syndrome	0.0183	0.0448	CcSEcCtD
Zalcitabine—CYP3A43—endocrine gland—polycystic ovary syndrome	0.0175	0.0627	CbGeAlD
Zalcitabine—Gemcitabine—RRM2—polycystic ovary syndrome	0.0175	1	CrCbGaD
Zalcitabine—CYP2C9—urine—polycystic ovary syndrome	0.0164	0.0589	CbGeAlD
Zalcitabine—Loose stools—Metformin—polycystic ovary syndrome	0.0164	0.0402	CcSEcCtD
Zalcitabine—Toothache—Metformin—polycystic ovary syndrome	0.015	0.0366	CcSEcCtD
Zalcitabine—SLC29A2—adipose tissue—polycystic ovary syndrome	0.0145	0.052	CbGeAlD
Zalcitabine—Respiratory distress—Metformin—polycystic ovary syndrome	0.0143	0.0351	CcSEcCtD
Zalcitabine—Nail disorder—Metformin—polycystic ovary syndrome	0.014	0.0344	CcSEcCtD
Zalcitabine—Heartburn—Metformin—polycystic ovary syndrome	0.0132	0.0324	CcSEcCtD
Zalcitabine—SLC29A2—adrenal gland—polycystic ovary syndrome	0.013	0.0466	CbGeAlD
Zalcitabine—CYP3A4—urine—polycystic ovary syndrome	0.0125	0.0449	CbGeAlD
Zalcitabine—CYP2D6—urine—polycystic ovary syndrome	0.0123	0.0442	CbGeAlD
Zalcitabine—SLC29A2—vagina—polycystic ovary syndrome	0.0121	0.0432	CbGeAlD
Zalcitabine—SLC29A2—endocrine gland—polycystic ovary syndrome	0.0113	0.0404	CbGeAlD
Zalcitabine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0112	0.0275	CcSEcCtD
Zalcitabine—Rigors—Metformin—polycystic ovary syndrome	0.0111	0.0273	CcSEcCtD
Zalcitabine—DCK—embryo—polycystic ovary syndrome	0.0104	0.0373	CbGeAlD
Zalcitabine—Chest discomfort—Metformin—polycystic ovary syndrome	0.0103	0.0252	CcSEcCtD
Zalcitabine—SLC29A1—adrenal cortex—polycystic ovary syndrome	0.00895	0.032	CbGeAlD
Zalcitabine—DCK—adrenal cortex—polycystic ovary syndrome	0.00855	0.0306	CbGeAlD
Zalcitabine—SLC29A1—endometrium—polycystic ovary syndrome	0.00799	0.0286	CbGeAlD
Zalcitabine—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00787	0.0282	CbGeAlD
Zalcitabine—Ear pain—Metformin—polycystic ovary syndrome	0.00774	0.019	CcSEcCtD
Zalcitabine—DCK—endometrium—polycystic ovary syndrome	0.00763	0.0273	CbGeAlD
Zalcitabine—SLC29A1—uterus—polycystic ovary syndrome	0.00736	0.0263	CbGeAlD
Zalcitabine—SLC22A7—endocrine gland—polycystic ovary syndrome	0.00726	0.026	CbGeAlD
Zalcitabine—SLC29A1—pituitary gland—polycystic ovary syndrome	0.00723	0.0259	CbGeAlD
Zalcitabine—SLC29A1—adipose tissue—polycystic ovary syndrome	0.0072	0.0258	CbGeAlD
Zalcitabine—DCK—uterus—polycystic ovary syndrome	0.00703	0.0252	CbGeAlD
Zalcitabine—Renal impairment—Metformin—polycystic ovary syndrome	0.00694	0.017	CcSEcCtD
Zalcitabine—DCK—pituitary gland—polycystic ovary syndrome	0.00691	0.0247	CbGeAlD
Zalcitabine—DCK—adipose tissue—polycystic ovary syndrome	0.00688	0.0246	CbGeAlD
Zalcitabine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00676	0.0166	CcSEcCtD
Zalcitabine—Pain in extremity—Metformin—polycystic ovary syndrome	0.0066	0.0162	CcSEcCtD
Zalcitabine—Migraine—Metformin—polycystic ovary syndrome	0.0065	0.0159	CcSEcCtD
Zalcitabine—SLC29A1—adrenal gland—polycystic ovary syndrome	0.00646	0.0231	CbGeAlD
Zalcitabine—DCK—adrenal gland—polycystic ovary syndrome	0.00617	0.0221	CbGeAlD
Zalcitabine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00603	0.0148	CcSEcCtD
Zalcitabine—SLC29A1—female gonad—polycystic ovary syndrome	0.00602	0.0216	CbGeAlD
Zalcitabine—SLC29A1—vagina—polycystic ovary syndrome	0.00598	0.0214	CbGeAlD
Zalcitabine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00595	0.0146	CcSEcCtD
Zalcitabine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0059	0.0145	CcSEcCtD
Zalcitabine—DCK—female gonad—polycystic ovary syndrome	0.00575	0.0206	CbGeAlD
Zalcitabine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00574	0.0141	CcSEcCtD
Zalcitabine—DCK—vagina—polycystic ovary syndrome	0.00572	0.0205	CbGeAlD
Zalcitabine—SLC29A1—endocrine gland—polycystic ovary syndrome	0.0056	0.02	CbGeAlD
Zalcitabine—Pancreatitis—Metformin—polycystic ovary syndrome	0.00559	0.0137	CcSEcCtD
Zalcitabine—Sweating increased—Metformin—polycystic ovary syndrome	0.00556	0.0136	CcSEcCtD
Zalcitabine—DCK—endocrine gland—polycystic ovary syndrome	0.00535	0.0191	CbGeAlD
Zalcitabine—Neutropenia—Metformin—polycystic ovary syndrome	0.00534	0.0131	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00499	0.0122	CcSEcCtD
Zalcitabine—Rhinitis—Metformin—polycystic ovary syndrome	0.00458	0.0112	CcSEcCtD
Zalcitabine—Hepatitis—Metformin—polycystic ovary syndrome	0.00457	0.0112	CcSEcCtD
Zalcitabine—Eye disorder—Metformin—polycystic ovary syndrome	0.00427	0.0105	CcSEcCtD
Zalcitabine—Flushing—Metformin—polycystic ovary syndrome	0.00424	0.0104	CcSEcCtD
Zalcitabine—Chills—Metformin—polycystic ovary syndrome	0.0041	0.01	CcSEcCtD
Zalcitabine—Flatulence—Metformin—polycystic ovary syndrome	0.00392	0.0096	CcSEcCtD
Zalcitabine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00389	0.00954	CcSEcCtD
Zalcitabine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00382	0.00936	CcSEcCtD
Zalcitabine—Vision blurred—Metformin—polycystic ovary syndrome	0.00375	0.00918	CcSEcCtD
Zalcitabine—Tremor—Metformin—polycystic ovary syndrome	0.00373	0.00913	CcSEcCtD
Zalcitabine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00369	0.00904	CcSEcCtD
Zalcitabine—Malaise—Metformin—polycystic ovary syndrome	0.00359	0.00878	CcSEcCtD
Zalcitabine—Syncope—Metformin—polycystic ovary syndrome	0.00357	0.00873	CcSEcCtD
Zalcitabine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00356	0.0127	CbGeAlD
Zalcitabine—Palpitations—Metformin—polycystic ovary syndrome	0.00351	0.00861	CcSEcCtD
Zalcitabine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00349	0.00856	CcSEcCtD
Zalcitabine—Hypertension—Metformin—polycystic ovary syndrome	0.00343	0.00841	CcSEcCtD
Zalcitabine—Myalgia—Metformin—polycystic ovary syndrome	0.00338	0.00829	CcSEcCtD
Zalcitabine—Discomfort—Metformin—polycystic ovary syndrome	0.00334	0.00819	CcSEcCtD
Zalcitabine—Oedema—Metformin—polycystic ovary syndrome	0.00324	0.00795	CcSEcCtD
Zalcitabine—Infection—Metformin—polycystic ovary syndrome	0.00322	0.0079	CcSEcCtD
Zalcitabine—Shock—Metformin—polycystic ovary syndrome	0.00319	0.00782	CcSEcCtD
Zalcitabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00318	0.00778	CcSEcCtD
Zalcitabine—Skin disorder—Metformin—polycystic ovary syndrome	0.00315	0.00772	CcSEcCtD
Zalcitabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00314	0.00768	CcSEcCtD
Zalcitabine—Anorexia—Metformin—polycystic ovary syndrome	0.00309	0.00758	CcSEcCtD
Zalcitabine—CYP3A5—female gonad—polycystic ovary syndrome	0.00298	0.0107	CbGeAlD
Zalcitabine—CYP3A5—vagina—polycystic ovary syndrome	0.00296	0.0106	CbGeAlD
Zalcitabine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00296	0.00724	CcSEcCtD
Zalcitabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00289	0.00709	CcSEcCtD
Zalcitabine—Somnolence—Metformin—polycystic ovary syndrome	0.00288	0.00707	CcSEcCtD
Zalcitabine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00286	0.007	CcSEcCtD
Zalcitabine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00282	0.00691	CcSEcCtD
Zalcitabine—Fatigue—Metformin—polycystic ovary syndrome	0.0028	0.00685	CcSEcCtD
Zalcitabine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00277	0.00992	CbGeAlD
Zalcitabine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00273	0.00976	CbGeAlD
Zalcitabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00267	0.00655	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00265	0.0065	CcSEcCtD
Zalcitabine—Urticaria—Metformin—polycystic ovary syndrome	0.00258	0.00631	CcSEcCtD
Zalcitabine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00257	0.00628	CcSEcCtD
Zalcitabine—Asthenia—Metformin—polycystic ovary syndrome	0.00233	0.0057	CcSEcCtD
Zalcitabine—Pruritus—Metformin—polycystic ovary syndrome	0.0023	0.00562	CcSEcCtD
Zalcitabine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00222	0.00544	CcSEcCtD
Zalcitabine—CYP2D6—female gonad—polycystic ovary syndrome	0.0022	0.00787	CbGeAlD
Zalcitabine—Dizziness—Metformin—polycystic ovary syndrome	0.00215	0.00526	CcSEcCtD
Zalcitabine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00208	0.00744	CbGeAlD
Zalcitabine—Vomiting—Metformin—polycystic ovary syndrome	0.00206	0.00505	CcSEcCtD
Zalcitabine—Rash—Metformin—polycystic ovary syndrome	0.00205	0.00501	CcSEcCtD
Zalcitabine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00205	0.00732	CbGeAlD
Zalcitabine—Dermatitis—Metformin—polycystic ovary syndrome	0.00204	0.00501	CcSEcCtD
Zalcitabine—Headache—Metformin—polycystic ovary syndrome	0.00203	0.00498	CcSEcCtD
Zalcitabine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000285	0.000965	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LPCAT2—polycystic ovary syndrome	0.000284	0.000964	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SUOX—polycystic ovary syndrome	0.000284	0.000964	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000283	0.000959	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000282	0.000957	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—RRM2—polycystic ovary syndrome	0.000281	0.000952	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000281	0.000952	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000278	0.000944	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000277	0.00094	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—RRM2—polycystic ovary syndrome	0.000277	0.000938	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000276	0.000935	CbGpPWpGaD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000272	0.000923	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—YAP1—polycystic ovary syndrome	0.000271	0.000918	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—YAP1—polycystic ovary syndrome	0.000267	0.000904	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ISYNA1—polycystic ovary syndrome	0.000264	0.000896	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—POMC—polycystic ovary syndrome	0.000263	0.000893	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NAMPT—polycystic ovary syndrome	0.00026	0.000882	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000257	0.000872	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000257	0.000872	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP11A1—polycystic ovary syndrome	0.000257	0.000871	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NAMPT—polycystic ovary syndrome	0.000256	0.000869	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000255	0.000866	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000255	0.000864	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP11A1—polycystic ovary syndrome	0.000253	0.000858	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000253	0.000857	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000252	0.000854	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000244	0.000827	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKR1C3—polycystic ovary syndrome	0.000243	0.000823	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000242	0.000821	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00024	0.000813	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKR1C3—polycystic ovary syndrome	0.000239	0.00081	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP17A1—polycystic ovary syndrome	0.000239	0.00081	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP17A1—polycystic ovary syndrome	0.000235	0.000797	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000226	0.000766	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000225	0.000764	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	0.000225	0.000762	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	0.000225	0.000762	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000225	0.000762	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000224	0.000758	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000223	0.000757	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000223	0.000756	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000223	0.000756	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000222	0.000754	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00022	0.000747	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000215	0.000731	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—TH—polycystic ovary syndrome	0.000207	0.000701	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000206	0.000697	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000205	0.000697	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000205	0.000697	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000204	0.000693	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000204	0.000691	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—TH—polycystic ovary syndrome	0.000203	0.00069	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—SLC2A4—polycystic ovary syndrome	0.000201	0.000682	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.0002	0.000679	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—SLC2A4—polycystic ovary syndrome	0.000198	0.000671	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000197	0.00067	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000195	0.000661	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000191	0.000648	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.00019	0.000646	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP19A1—polycystic ovary syndrome	0.000189	0.000641	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	0.000188	0.000639	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000186	0.000632	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000186	0.000631	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP19A1—polycystic ovary syndrome	0.000186	0.000631	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000184	0.000623	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000182	0.000616	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00018	0.000611	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000179	0.000607	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000178	0.000605	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000178	0.000602	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000171	0.00058	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.00017	0.000577	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GNAS—polycystic ovary syndrome	0.000169	0.000572	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000167	0.000565	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GNAS—polycystic ovary syndrome	0.000166	0.000563	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000166	0.000562	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000162	0.000551	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000162	0.000551	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NCOR1—polycystic ovary syndrome	0.000161	0.000545	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00016	0.000542	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000158	0.000537	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NCOR1—polycystic ovary syndrome	0.000158	0.000537	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1A1—polycystic ovary syndrome	0.000152	0.000517	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000152	0.000515	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000151	0.000512	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1A1—polycystic ovary syndrome	0.00015	0.000509	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000148	0.000501	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000147	0.0005	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000146	0.000495	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000146	0.000495	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000145	0.000493	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000145	0.000491	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000145	0.000491	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000145	0.000491	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000143	0.000485	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTHFR—polycystic ovary syndrome	0.000142	0.000482	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTHFR—polycystic ovary syndrome	0.00014	0.000474	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000136	0.000462	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000136	0.000461	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000135	0.000459	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000135	0.000457	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000134	0.000455	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000132	0.000448	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000132	0.000446	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000129	0.000438	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000129	0.000438	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000125	0.000424	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000123	0.000417	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000123	0.000417	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000119	0.000403	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000117	0.000397	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000117	0.000395	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000115	0.000392	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000115	0.000392	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—polycystic ovary syndrome	0.000115	0.00039	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000115	0.00039	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000114	0.000388	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000114	0.000388	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—POMC—polycystic ovary syndrome	0.000114	0.000385	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—polycystic ovary syndrome	0.000113	0.000385	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—INS—polycystic ovary syndrome	0.000113	0.000383	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—POMC—polycystic ovary syndrome	0.000112	0.000379	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000111	0.000378	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—INS—polycystic ovary syndrome	0.000111	0.000377	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00011	0.000373	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.00011	0.000372	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000108	0.000368	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000107	0.000364	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000105	0.000355	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000104	0.000354	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.000103	0.00035	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000102	0.000346	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	9.68e-05	0.000328	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	9.62e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	9.59e-05	0.000325	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.55e-05	0.000324	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.55e-05	0.000324	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	9.54e-05	0.000324	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	9.47e-05	0.000321	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	9.33e-05	0.000316	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	9.17e-05	0.000311	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.1e-05	0.000308	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	9.03e-05	0.000306	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.88e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.85e-05	0.0003	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	8.75e-05	0.000297	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	8.68e-05	0.000294	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.58e-05	0.000291	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	8.31e-05	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TH—polycystic ovary syndrome	8.2e-05	0.000278	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	8.05e-05	0.000273	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	7.97e-05	0.00027	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	7.8e-05	0.000265	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	7.76e-05	0.000263	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	7.73e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.55e-05	0.000256	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.55e-05	0.000256	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	7.5e-05	0.000254	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	7.46e-05	0.000253	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	7.44e-05	0.000252	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.38e-05	0.00025	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	7.36e-05	0.00025	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.29e-05	0.000247	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	6.96e-05	0.000236	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.91e-05	0.000234	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	6.85e-05	0.000232	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	6.79e-05	0.00023	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	6.73e-05	0.000228	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	6.69e-05	0.000227	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	6.63e-05	0.000225	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	6.58e-05	0.000223	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	6.42e-05	0.000218	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	6.37e-05	0.000216	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.37e-05	0.000216	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.33e-05	0.000215	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	6.04e-05	0.000205	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6e-05	0.000203	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.92e-05	0.000201	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	5.91e-05	0.0002	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.86e-05	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.76e-05	0.000195	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	5.73e-05	0.000194	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.72e-05	0.000194	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.68e-05	0.000192	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	5.63e-05	0.000191	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	5.52e-05	0.000187	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.47e-05	0.000186	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	5.42e-05	0.000184	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	5.3e-05	0.00018	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.26e-05	0.000178	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	5.24e-05	0.000178	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.23e-05	0.000177	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.19e-05	0.000176	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.15e-05	0.000175	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.1e-05	0.000173	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.95e-05	0.000168	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.9e-05	0.000166	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.87e-05	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.87e-05	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.84e-05	0.000164	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.83e-05	0.000164	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.61e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	4.57e-05	0.000155	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	4.5e-05	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—INS—polycystic ovary syndrome	4.48e-05	0.000152	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.44e-05	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	4.37e-05	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.34e-05	0.000147	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.21e-05	0.000143	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.2e-05	0.000142	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.18e-05	0.000142	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.1e-05	0.000139	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	4.07e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.06e-05	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.87e-05	0.000131	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.85e-05	0.000131	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.82e-05	0.00013	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.74e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.61e-05	0.000122	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.47e-05	0.000118	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.44e-05	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.42e-05	0.000116	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.41e-05	0.000116	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.3e-05	0.000112	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.28e-05	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.26e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.25e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.24e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.23e-05	0.00011	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.18e-05	0.000108	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.11e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.08e-05	0.000104	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.9e-05	9.82e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.87e-05	9.73e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.75e-05	9.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.68e-05	9.09e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.52e-05	8.54e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.35e-05	7.96e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.33e-05	7.89e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.32e-05	7.85e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.3e-05	7.81e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.3e-05	7.78e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.28e-05	7.74e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.25e-05	7.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.14e-05	7.26e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.03e-05	6.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.89e-05	6.42e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.54e-05	5.21e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.51e-05	5.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.51e-05	5.11e-05	CbGpPWpGaD
